Aptar Pharma has announced the launch of its new eDose counter for MDIs at RDD 2016. According to the company, the eDose counter can be used with any metering valve; the counter's sensor detects the MDI spray directly to minimize the risk of miscounts; and the device provides priming and medication reminders. Aptar Pharma Prescription Division President Jean-Marc … [Read more...] about Aptar Pharma launches eDose counter for MDIs
News
GSK opens new £56 million inhaler manufacturing facility
GlaxoSmithKline has opened a new £56 million, 4500 m2 manufacturing facility for its Ellipta DPI products. According to GSK, the new facility will create 150 jobs and will double production of Ellipta inhalers at the site to over 37 million per year by 2017. In December 2013, the company announced that it would invest ~ £200 million in UK manufacturing sites, … [Read more...] about GSK opens new £56 million inhaler manufacturing facility
Discovery Laboratories becomes Windtree Therapeutics
Discovery Laboratories, which is developing Aerosurf aerosolized KL4 surfactant for the treatment of respiratory distress syndrome in premature infants, has changed its name to Windtree Therapeutics, the company said. CEO Craig Fraser, who was appointed in February 2016, commented, "Today marks a new direction in the pursuit of our mission to save and improve … [Read more...] about Discovery Laboratories becomes Windtree Therapeutics
Recipharm acquires Kemwell’s Cirrus Pharmaceuticals
Swedish CDMO Recipharm has announced that it will acquire Kemwell's CDMO business, including North Carolina-based Cirrus Pharmaceuticals. Kemwell acquired Cirrus Pharmaceuticals, which offers OINDP development and manufacturing services, in 2013. In February 2016, Cirrus Pharmaceuticals announced that it had added cGMP inhaler manufacturing services for early … [Read more...] about Recipharm acquires Kemwell’s Cirrus Pharmaceuticals
MVIC appoints Lars Asking as VP
The Medicon Valley Inhalation Consortium (MVIC) has announced the appointment of Lars Asking as VP as of May 1, 2016. Asking was most recently Principle Scientist at Novo Nordisk and previously developed inhaled products at LAB Pharma and AstraZeneca. MVIC is comprised of 24 member companies with expertise in various areas of inhaled product development. In … [Read more...] about MVIC appoints Lars Asking as VP
Freeman Technology expands in China and Europe
Powder characterization specialist Freeman Technology has announced that its Chinese operations have moved into a larger facility equipped with a laboratory and that the company has hired Tom Qin as General Manager and Ruty Li as National Sales Manager in China. In Europe, the company has added Alfatest Srl as a new distributor in Italy and Pragolab in the Czech … [Read more...] about Freeman Technology expands in China and Europe
Mast Therapeutics announces Phase 2 study of AIR001by the Heart Failure Clinical Research Network
Mast Therapeutics has announced that the Duke Clinical Research Institute will serve as the coordinating center for the Heart Failure Clinical Research Network (HFN) as it conducts a Phase 2 study of AIR001 sodium nitrite inhalation solution. Earlier this year, Mast reported positive results from a Phase 2a AIR001 for the treatment of heart failure that was conducted … [Read more...] about Mast Therapeutics announces Phase 2 study of AIR001by the Heart Failure Clinical Research Network
Quotient Clinical adds spray drying capacity
Quotient Clinical's new GMP facility in Nottingham, UK will include added spray drying capacity for spray drying of batches up to 2 kilograms. The facility is scheduled to open later this year. Quotient Clinical's inhaled drug development work has included a partnership with Pulmatrix on its PUR0200 DPI. Quotient Clinical VP of Pharmaceutical Sciences Nikki … [Read more...] about Quotient Clinical adds spray drying capacity
Hovione creates new company to sell devices
Hovione has announced the launch of a new company called Hovione Technology, which "focuses on offering an inhaler that matches your product, your needs, your patients." The company's devices include the Twin Caps and PowdAir capsule-based dry powder inhalers. According to an email from the company, Hovione Technology is "a Hovione Ventures company"; both … [Read more...] about Hovione creates new company to sell devices
Raptor launches Quinsair inhaled levofloxacin in Europe
Raptor Pharmaceutical has launched Quinsair levofloxacin inhalation solution for the treatment of P. aeruginosa infections in cystic fibrosis patients in Germany and Denmark, the company said. According to Raptor, it plans to launch Quinsair in Canada and in additional European countries later this year. Raptor acquired Quinsair, formerly called Aeroquin, in … [Read more...] about Raptor launches Quinsair inhaled levofloxacin in Europe